AI
ABBV icon

Atria Investments’s AbbVie ABBV Stock Holding History

Atria Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8M Buy
154,317
+2,030
+1% +$437K 0.39% 42
2026
Q1 		$33.1M Sell
152,287
-16,380
-10% -$3.63M 0.37% 47
2025
Q4 		$38.5M Buy
168,667
+1,159
+0.7% +$264K 0.44% 36
2025
Q3 		$38.8M Sell
167,508
-10,865
-6% -$2.21M 0.44% 37
2025
Q2 		$33.1M Sell
178,373
-10,819
-6% -$2.01M 0.39% 39
2025
Q1 		$39.6M Buy
189,192
+14,335
+8% +$2.79M 0.51% 28
2024
Q4 		$31.1M Buy
174,857
+4,237
+2% +$779K 0.39% 42
2024
Q3 		$33.7M Buy
170,620
+3,065
+2% +$572K 0.42% 41
2024
Q2 		$28.7M Sell
167,555
-9,949
-6% -$1.65M 0.37% 49
2024
Q1 		$32.3M Buy
177,504
+12,609
+8% +$2.17M 0.44% 43
2023
Q4 		$25.5M Buy
164,895
+6,663
+4% +$971K 0.4% 47
2023
Q3 		$23.6M Buy
158,232
+9,994
+7% +$1.47M 0.42% 44
2023
Q2 		$20M Sell
148,238
-14,483
-9% -$2.12M 0.36% 54
2023
Q1 		$25.9M Buy
162,721
+11,728
+8% +$1.79M 0.49% 34
2022
Q4 		$24.4M Buy
150,993
+8,259
+6% +$1.27M 0.5% 31
2022
Q3 		$19.2M Sell
142,734
-7,811
-5% -$1.12M 0.42% 39
2022
Q2 		$23.1M Sell
150,545
-8,073
-5% -$1.23M 0.48% 33
2022
Q1 		$25.7M Buy
158,618
+18,858
+13% +$2.74M 0.45% 37
2021
Q4 		$18.9M Buy
139,760
+11,233
+9% +$1.33M 0.34% 61
2021
Q3 		$13.9M Buy
128,527
+9,982
+8% +$1.14M 0.25% 86
2021
Q2 		$13.4M Buy
118,545
+23,262
+24% +$2.62M 0.26% 83
2021
Q1 		$10.3M Buy
95,283
+8,890
+10% +$951K 0.23% 101
2020
Q4 		$9.26M Buy
86,393
+9,788
+13% +$941K 0.22% 108
2020
Q3 		$6.71M Buy
76,605
+6,443
+9% +$607K 0.2% 114
2020
Q2 		$6.89M Buy
70,162
+4,803
+7% +$423K 0.24% 104
2020
Q1 		$4.98M Buy
65,359
+13,737
+27% +$1.17M 0.38% 65
2019
Q4 		$4.57M Buy
51,622
+21,077
+69% +$1.75M 0.12% 166
2019
Q3 		$2.31M Buy
30,545
+2,731
+10% +$187K 0.08% 201
2019
Q2 		$1.8M Buy
+27,814
New +$2.19M 0.07% 249
2019
Q1 		– Sell
-32,582
Closed -$3M – 920
2018
Q4 		$3M Buy
32,582
+1,962
+6% +$173K 0.13% 124
2018
Q3 		$2.9M Sell
30,620
-23,688
-44% -$2.25M 0.11% 158
2018
Q2 		$5.03M Buy
54,308
+4,459
+9% +$435K 0.22% 81
2018
Q1 		$4.72M Buy
49,849
+890
+2% +$97.8K 0.23% 78
2017
Q4 		$4.74M Sell
48,959
-28,210
-37% -$2.66M 0.24% 76
2017
Q3 		$6.86M Sell
77,169
-7,998
-9% -$609K 0.37% 49
2017
Q2 		$6.17M Buy
85,167
+292
+0.3% +$19.6K 0.38% 47
2017
Q1 		$5.53M Buy
84,875
+13,815
+19% +$869K 0.36% 50
2016
Q4 		$4.45M Buy
71,060
+15,337
+28% +$936K 0.34% 49
2016
Q3 		$3.51M Buy
55,723
+6,959
+14% +$451K 0.32% 51
2016
Q2 		$3.08M Buy
48,764
+25,575
+110% +$1.56M 0.33% 42
2016
Q1 		$1.32M Buy
23,189
+4,576
+25% +$255K 0.15% 105
2015
Q4 		$1.04M Buy
18,613
+2,266
+14% +$131K 0.11% 130
2015
Q3 		$889K Sell
16,347
-532
-3% -$34.6K 0.12% 124
2015
Q2 		$1.13M Sell
16,879
-758
-4% -$49.5K 0.13% 113
2015
Q1 		$1.03M Buy
17,637
+2,252
+15% +$136K 0.12% 143
2014
Q4 		$1.01M Buy
15,385
+194
+1% +$12.2K 0.11% 157
2014
Q3 		$877K Buy
15,191
+438
+3% +$24.3K 0.09% 194
2014
Q2 		$833K Sell
14,753
-1,390
-9% -$72.9K 0.08% 204
2014
Q1 		$830K Sell
16,143
-263
-2% -$13.3K 0.08% 195
2013
Q4 		$866K Sell
16,406
-2,379
-13% -$117K 0.09% 205
2013
Q3 		$840K Buy
18,785
+1,325
+8% +$58.7K 0.09% 193
2013
Q2 		$722K Buy
+17,460
New +$764K 0.09% 137

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Atria Investments's ABBV Position: Q2 2026 in Review

Atria Investments increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $437K and bringing the position to 154,317 shares worth $38.8M. The position accounts for 0.39% of the portfolio, ranked #42.

Atria Investments first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $39.6M in Q1 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Atria Investments held 154,317 shares of AbbVie worth $38.8M as of Q2 2026.
  • Atria Investments bought 2,030 AbbVie shares in Q2 2026, an estimated $437K.
  • AbbVie made up 0.39% of Atria Investments's portfolio in Q2 2026, its #42 holding.
  • Atria Investments first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Atria Investments's AbbVie position peaked at $39.6M in Q1 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.